Cargando…

Sustained inhibition of CC-chemokine receptor-2 via intraarticular deposition of polymeric microplates in post-traumatic osteoarthritis

Posttraumatic osteoarthritis (PTOA) is mostly treated via corticosteroid administration, and total joint arthroplasty continues to be the sole effective intervention in severe conditions. To assess the therapeutic potential of CCR2 targeting in PTOA, we used biodegradable microplates (µPLs) to achie...

Descripción completa

Detalles Bibliográficos
Autores principales: Ozkan, Huseyin, Di Francesco, Martina, Willcockson, Helen, Valdés-Fernández, José, Di Francesco, Valentina, Granero-Moltó, Froilán, Prósper, Felipe, Decuzzi, Paolo, Longobardi, Lara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794532/
https://www.ncbi.nlm.nih.gov/pubmed/36109442
http://dx.doi.org/10.1007/s13346-022-01235-1
_version_ 1784860056939921408
author Ozkan, Huseyin
Di Francesco, Martina
Willcockson, Helen
Valdés-Fernández, José
Di Francesco, Valentina
Granero-Moltó, Froilán
Prósper, Felipe
Decuzzi, Paolo
Longobardi, Lara
author_facet Ozkan, Huseyin
Di Francesco, Martina
Willcockson, Helen
Valdés-Fernández, José
Di Francesco, Valentina
Granero-Moltó, Froilán
Prósper, Felipe
Decuzzi, Paolo
Longobardi, Lara
author_sort Ozkan, Huseyin
collection PubMed
description Posttraumatic osteoarthritis (PTOA) is mostly treated via corticosteroid administration, and total joint arthroplasty continues to be the sole effective intervention in severe conditions. To assess the therapeutic potential of CCR2 targeting in PTOA, we used biodegradable microplates (µPLs) to achieve a slow and sustained intraarticular release of the CCR2 inhibitor RS504393 into injured knees and followed joint damage during disease progression. RS504393-loaded µPLs (RS-µPLs) were fabricated via a template-replica molding technique. A mixture of poly(lactic-co-glycolic acid) (PLGA) and RS504393 was deposited into 20 × 10 μm (length × height) wells in a polyvinyl alcohol (PVA) square-patterned template. After physicochemical and toxicological characterizations, the RS504393 release profile from µPL was assessed in PBS buffer. C57BL/6 J male mice were subjected to destabilization of the medial meniscus (DMM)/sham surgery, and RS-µPLs (1 mg/kg) were administered intraarticularly 1 week postsurgery. Administrations were repeated at 4 and 7 weeks post-DMM. Drug free-µPLs (DF-µPLs) and saline injections were performed as controls. Mice were euthanized at 4 and 10 weeks post-DMM, corresponding to the early and severe PTOA stages, respectively. Knees were evaluated for cartilage structure score (ACS, H&E), matrix loss (safranin O score), osteophyte formation and maturation from cartilage to bone (cartilage quantification), and subchondral plate thickness. The RS-µPL architecture ensured the sustained release of CCR2 inhibitors over several weeks, with ~ 20% of RS504393 still available at 21 days. This prolonged release improved cartilage structure and reduced bone damage and synovial hyperplasia at both PTOA stages. Extracellular matrix loss was also attenuated, although with less efficacy. The results indicate that local sustained delivery is needed to optimize CCR2-targeted therapies. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s13346-022-01235-1.
format Online
Article
Text
id pubmed-9794532
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-97945322022-12-29 Sustained inhibition of CC-chemokine receptor-2 via intraarticular deposition of polymeric microplates in post-traumatic osteoarthritis Ozkan, Huseyin Di Francesco, Martina Willcockson, Helen Valdés-Fernández, José Di Francesco, Valentina Granero-Moltó, Froilán Prósper, Felipe Decuzzi, Paolo Longobardi, Lara Drug Deliv Transl Res Original Article Posttraumatic osteoarthritis (PTOA) is mostly treated via corticosteroid administration, and total joint arthroplasty continues to be the sole effective intervention in severe conditions. To assess the therapeutic potential of CCR2 targeting in PTOA, we used biodegradable microplates (µPLs) to achieve a slow and sustained intraarticular release of the CCR2 inhibitor RS504393 into injured knees and followed joint damage during disease progression. RS504393-loaded µPLs (RS-µPLs) were fabricated via a template-replica molding technique. A mixture of poly(lactic-co-glycolic acid) (PLGA) and RS504393 was deposited into 20 × 10 μm (length × height) wells in a polyvinyl alcohol (PVA) square-patterned template. After physicochemical and toxicological characterizations, the RS504393 release profile from µPL was assessed in PBS buffer. C57BL/6 J male mice were subjected to destabilization of the medial meniscus (DMM)/sham surgery, and RS-µPLs (1 mg/kg) were administered intraarticularly 1 week postsurgery. Administrations were repeated at 4 and 7 weeks post-DMM. Drug free-µPLs (DF-µPLs) and saline injections were performed as controls. Mice were euthanized at 4 and 10 weeks post-DMM, corresponding to the early and severe PTOA stages, respectively. Knees were evaluated for cartilage structure score (ACS, H&E), matrix loss (safranin O score), osteophyte formation and maturation from cartilage to bone (cartilage quantification), and subchondral plate thickness. The RS-µPL architecture ensured the sustained release of CCR2 inhibitors over several weeks, with ~ 20% of RS504393 still available at 21 days. This prolonged release improved cartilage structure and reduced bone damage and synovial hyperplasia at both PTOA stages. Extracellular matrix loss was also attenuated, although with less efficacy. The results indicate that local sustained delivery is needed to optimize CCR2-targeted therapies. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s13346-022-01235-1. Springer US 2022-09-15 2023 /pmc/articles/PMC9794532/ /pubmed/36109442 http://dx.doi.org/10.1007/s13346-022-01235-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Ozkan, Huseyin
Di Francesco, Martina
Willcockson, Helen
Valdés-Fernández, José
Di Francesco, Valentina
Granero-Moltó, Froilán
Prósper, Felipe
Decuzzi, Paolo
Longobardi, Lara
Sustained inhibition of CC-chemokine receptor-2 via intraarticular deposition of polymeric microplates in post-traumatic osteoarthritis
title Sustained inhibition of CC-chemokine receptor-2 via intraarticular deposition of polymeric microplates in post-traumatic osteoarthritis
title_full Sustained inhibition of CC-chemokine receptor-2 via intraarticular deposition of polymeric microplates in post-traumatic osteoarthritis
title_fullStr Sustained inhibition of CC-chemokine receptor-2 via intraarticular deposition of polymeric microplates in post-traumatic osteoarthritis
title_full_unstemmed Sustained inhibition of CC-chemokine receptor-2 via intraarticular deposition of polymeric microplates in post-traumatic osteoarthritis
title_short Sustained inhibition of CC-chemokine receptor-2 via intraarticular deposition of polymeric microplates in post-traumatic osteoarthritis
title_sort sustained inhibition of cc-chemokine receptor-2 via intraarticular deposition of polymeric microplates in post-traumatic osteoarthritis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794532/
https://www.ncbi.nlm.nih.gov/pubmed/36109442
http://dx.doi.org/10.1007/s13346-022-01235-1
work_keys_str_mv AT ozkanhuseyin sustainedinhibitionofccchemokinereceptor2viaintraarticulardepositionofpolymericmicroplatesinposttraumaticosteoarthritis
AT difrancescomartina sustainedinhibitionofccchemokinereceptor2viaintraarticulardepositionofpolymericmicroplatesinposttraumaticosteoarthritis
AT willcocksonhelen sustainedinhibitionofccchemokinereceptor2viaintraarticulardepositionofpolymericmicroplatesinposttraumaticosteoarthritis
AT valdesfernandezjose sustainedinhibitionofccchemokinereceptor2viaintraarticulardepositionofpolymericmicroplatesinposttraumaticosteoarthritis
AT difrancescovalentina sustainedinhibitionofccchemokinereceptor2viaintraarticulardepositionofpolymericmicroplatesinposttraumaticosteoarthritis
AT graneromoltofroilan sustainedinhibitionofccchemokinereceptor2viaintraarticulardepositionofpolymericmicroplatesinposttraumaticosteoarthritis
AT prosperfelipe sustainedinhibitionofccchemokinereceptor2viaintraarticulardepositionofpolymericmicroplatesinposttraumaticosteoarthritis
AT decuzzipaolo sustainedinhibitionofccchemokinereceptor2viaintraarticulardepositionofpolymericmicroplatesinposttraumaticosteoarthritis
AT longobardilara sustainedinhibitionofccchemokinereceptor2viaintraarticulardepositionofpolymericmicroplatesinposttraumaticosteoarthritis